More than 2,000 in U.S. diagnosed in vaping illness outbreak | Inquirer
 
 
 
 
 
 

More than 2,000 in U.S. diagnosed in vaping illness outbreak

/ 09:02 AM November 08, 2019

A woman using a vaping device exhales a puff of smoke in Mayfield Heights, Ohio. The Centers for Disease Control and Prevention confirmed Thursday, Nov. 7, 2019, that new government figures show more than 2,000 Americans have come down with vaping-related illnesses. Illnesses have occurred in every state but Alaska. AP PHOTO

NEW YORK — New government figures show more than 2,000 people have been diagnosed with vaping illnesses in the still-unsolved U.S. outbreak.

The Centers for Disease Control and Prevention on Thursday said 2,051 confirmed and probable cases have been reported. Illnesses have occurred in every state but Alaska. Forty people in 24 states have died.

The outbreak appears to have started in March. No single ingredient or vaping device has been linked to all the illnesses. Most who got sick said they vaped products containing THC, the high-inducing ingredient in marijuana.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Health officials urge people to avoid vaping, particularly products containing THC and purchased off the street.

The CDC said it tallied 39 deaths as of 5 p.m. Tuesday. Massachusetts reported an additional death Wednesday.

Want stories like this delivered straight to your inbox? Stay informed. Stay ahead. Subscribe to InqMORNING

Don't miss out on the latest news and information.
TAGS: vaping
For feedback, complaints, or inquiries, contact us.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.




This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.